Antiplatelet effects of citalopram in patients with ischaemic stroke: A randomized, placebo-controlled, double-blind study
Abstract We evaluated the effect of SSRI treatment on platelet aggregation in patients with ischaemic stroke and included patients from the randomized double-blind controlled study of citalopram in acute ischaemic stroke (TALOS). Patients on clopidogrel were included 6 months after acute ischaemic s...
Guardado en:
Autores principales: | Kristian Lundsgaard Kraglund, Janne Kaergaard Mortensen, Søren Paaske Johnsen, Grethe Andersen, Erik Lerkevang Grove |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f434cb39c17e4a90be2bbcf4822ac0d1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Precision antiplatelet therapy for the prevention of ischaemic stroke
por: David Wang -
Post-stroke mortality, stroke severity, and preadmission antipsychotic medicine use--a population-based cohort study.
por: Anders Prior, et al.
Publicado: (2014) -
Incidence of stroke, transient ischaemic attack and determinants of poststroke mortality among immigrants in Denmark, 2004‒2018: a population-based cohort study
por: Marie Norredam, et al.
Publicado: (2021) -
Secondary prevention medication persistence and prognosis of acute ischaemic stroke or transient ischaemic attack
por: Lei Zhang, et al.
Publicado: (2021) -
Central and cerebral haemodynamic changes after antihypertensive therapy in ischaemic stroke patients: A double-blind randomised trial
por: Mun Hee Choi, et al.
Publicado: (2018)